HOSPITAL
DAY PROCEDURE CENTRE
PROCEDURES
CLINICAL STAFF
FORMS
LINKS
EXPERTISE
RESEARCH
PUBLICATIONS
GI DISEASE INFORMATION
HEALTH TIPS
THE INSIDE STORY
RESISTANT H. PYLORI
COLON CANCER SCREENING
CONTACT US

 

 

EXPERTISE: Disease Information


Inflammatory Bowel Disease

 

Infection with Clostridium Difficile

Crohn's Disease   Diverticulosis & Diverticulitis
Ulcerative Colitis   Barrett's Oesophagus
Helicobacter Pylori   Rectal Bleeding
Coeliac Disease   Haemorrhoid Banding
Irritable Bowel Syndrome   Colonic Polyps
Parasites    

 

Coeliac Disease

Introduction

Coeliac disease is a digestive disease that damages the small intestine and interferes with absorption of nutrients. Patients with coeliac disease develop intolerance to a protein called gluten, which is found in wheat, rye, barley and oats. In such patients, when gluten is ingested the immune system responds by attacking the cells lining the small intestine. Specifically, tiny finger-like protrusions, called villi, are lost. These villi play a key role in the absorption of nutrients into the bloodstream. Without them, malnutrition ensues regardless of the quantity of food consumed.

Coeliac disease is also known as coeliac sprue, nontropical sprue, and gluten-sensitive enteropathy. Because the body's immune system causes the damage, coeliac disease is considered an autoimmune disorder. It is also classified as a disease of malabsorption.

The prevalence of coeliac disease in Australia may be as high as 1 in every 500 people. Patients may develop initial symptoms as children or adults. Coeliac disease is sometimes triggered or becomes active for the first time after surgery, pregnancy, childbirth, viral infection or severe emotional stress. One factor contributing to the development of coeliac disease may be breastfeeding during infancy - patients breastfed for a significant period of time tend to develop symptoms of coeliac disease later and have more atypical symptoms than those not breastfed as a child. The disease does not appear in children until after they begin eating gluten.

Symptoms

Coeliac disease may be asymptomatic in some patients where the undamaged part of the small intestine is able to absorb enough nutrients to prevent symptoms. There is no typical presentation. Common gastrointestinal symptoms include chronic diarrhoea, abdominal discomfort, bloating and distension. Symptoms may or may not occur in the digestive system. For example, one patient might have diarrhoea and abdominal pain, while another patient may complain of irritability or depression. In fact, irritability is one of the most common symptoms in children. Many symptoms (eg. fatigue, anaemia, weight loss, bone pain, delayed growth and failure to thrive in infants) are secondary to malnutrition. Other possible symptoms include behavioural changes, muscle cramps, tingling numbness in the limbs, mouth ulcers, dermatitis, tooth discolouration and missed menstrual periods.

Diagnosis

Coeliac disease can be difficult to diagnose because symptoms are similar to those of other diseases, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, diverticulosis, intestinal infections, chronic fatigue syndrome and depression. Diagnosis is suspected on the basis of the symptoms and signs, enhanced by laboratory and x-ray studies. Endoscopy may be performed whereby the Gastroenterologist introduces a flexible tube carrying a tiny camera through the mouth and stomach into the small intestine. This allows a sample of intestinal tissue (a biopsy) to be obtained for examination under the microscope and checked for damage to the intestinal lining and villi. Biopsy of the small intestine is the best way to diagnose coeliac disease. The diagnosis can then be confirmed by clinical and microscopic improvement on a gluten-free diet.

Antibodies are produced by the immune system in response to substances that the body perceives to be threatening. Coeliac disease may be diagnosed through the presence of antibodies to gluten in the blood. These antibodies are antigliadin, anti-reticulin, anti-endomysium and TTG(tissue trans-glutaminase). This is a non-invasive way to screen for coeliac disease in 'at risk' patients (eg. those with coeliac disease-suffering family members). Positive blood tests should be followed-up with an endoscopy, biopsy and histological analysis.

Treatment

The standard treatment for coeliac disease is to remove all gluten-containing foods from the diet. For many patients, this is enough to control symptoms, heal existing intestinal damage (the villi regain function) and prevent further damage. Improvements can begin within days of starting the diet and the small intestine is often completely healed within 3 to 6 months.

The gluten-free diet is a lifetime requirement. Eating any gluten, no matter how small an amount, can damage the intestine. This is true for anyone with the disease, including patients without noticeable symptoms. Depending on a person's age at diagnosis and the severity of the disease, some problems, such as delayed growth and tooth discoloration, may not improve.

A proportion of patients with coeliac disease do not improve on the gluten-free diet and need to receive nutritional supplements. Supplementary vitamins, minerals, especially iron, are given according to the deficiency. While mild cases of coeliac disease may not require any supplementation, severe cases require comprehensive intravenous replacement. Drug treatments are being evaluated for unresponsive coeliac disease. These patients may need to be monitored for signs of complications of the disease, which include lymphoma, osteoporosis and seizures among others.


Back Home



Centre for Digestive Diseases
Level 1, 229 Great North Road
Five Dock NSW 2046
AUSTRALIA

Telephone: 61 2 9713 4011
Fax: 61 2 9712 1675


© 2003 Centre for Digestive Diseases
Web Site Disclaimer
Site Map

 
 
ISO 9001 incl PSQC